Sorin Armeanu
Overview
Explore the profile of Sorin Armeanu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
570
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Warmann S, Armeanu S, Heitmann H, Ruck P, Seitz G, Wessels J, et al.
Pediatr Surg Int
. 2006 Aug;
22(9):733-42.
PMID: 16896819
Gene targeting is currently of distinct interest as an innovative additive treatment option in various malignancies. Its role in pediatric liver tumors has not yet been evaluated thoroughly. For the...
12.
Pathil A, Armeanu S, Venturelli S, Mascagni P, Weiss T, Gregor M, et al.
Hepatology
. 2006 Apr;
43(3):425-34.
PMID: 16583461
Hepatocellular carcinoma (HCC) displays a striking resistance to chemotherapeutic drugs or innovative tumor cell apoptosis-inducing agents such as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Recently, we found 2 histone deacetylase...
13.
Graepler F, Lemken M, Wybranietz W, Schmidt U, Smirnow I, Gross C, et al.
World J Gastroenterol
. 2006 Jan;
11(44):6910-9.
PMID: 16437592
Aim: To investigate the effects of catalytically superior gene-directed enzyme prodrug therapy systems on a rat hepatoma model. Methods: To increase hepatoma cell chemosensitivity for the prodrug 5-fluorocytosine (5-FC), we...
14.
Warmann S, Armeanu S, Frank H, Buck H, Graepler F, Lemken M, et al.
Pediatr Surg Int
. 2005 Dec;
22(1):16-23.
PMID: 16374644
Poor treatment results in advanced hepatoblastoma (HB) made alternative treatment approaches desirable. Gene-directed tumor therapy is increasingly investigated in different malignancies. The aim of this study was to analyze possible...
15.
Armeanu S, Bitzer M, Smirnow I, Bossow S, Appel S, Ungerechts G, et al.
J Immunol
. 2005 Oct;
175(8):4971-80.
PMID: 16210599
Delivery of Ags to dendritic cells (DCs) plays a pivotal role in the induction of efficient immune responses ranging from immunity to tolerance. The observation that certain viral pathogens are...
16.
Lemken M, Wybranietz W, Schmidt U, Graepler F, Armeanu S, Bitzer M, et al.
World J Gastroenterol
. 2005 Sep;
11(34):5295-302.
PMID: 16149135
Aim: To generate and characterize the synthetic transcriptional control units for transcriptional targeting of the liver, thereby compensating for the lack of specificity of currently available gene therapeutic vector systems....
17.
Armeanu S, Bitzer M, Lauer U, Venturelli S, Pathil A, Krusch M, et al.
Cancer Res
. 2005 Jul;
65(14):6321-9.
PMID: 16024634
Natural killer (NK) cells as components of the innate immunity substantially contribute to antitumor immune responses. However, the tumor-associated ligands engaging activating NK cell receptors are largely unknown. An exception...
18.
Armeanu S, Pathil A, Venturelli S, Mascagni P, Weiss T, Gottlicher M, et al.
J Hepatol
. 2005 Jan;
42(2):210-7.
PMID: 15664246
Background/aims: Due to a particular resistance against conventional chemotherapeutics, palliative treatment of hepatocellular carcinomas (HCC) is highly ineffective. Recent demonstration of both proliferation-inhibition and apoptosis of hepatoma cells by a...
19.
Bernloehr C, Bossow S, Ungerechts G, Armeanu S, Neubert W, Lauer U, et al.
Virus Res
. 2004 Jan;
99(2):193-7.
PMID: 14749185
Recombinant Sendai virus vectors (SeVV) have become an attractive tool for basic virological as well as for gene transfer studies. However, to (i) reduce the cellular injury induced by basic...
20.
Bitzer M, Armeanu S, Krober S, Horger M, Erley C
Lancet
. 2003 Nov;
362(9394):1456.
PMID: 14602441
No abstract available.